Jade Biosciences (JBIO) Common Equity (2020 - 2026)
Jade Biosciences' Common Equity was $439.92 million in Q2 2026, up 118.3% from $201.56 million a year earlier and up 48.4% from the prior quarter.
Powered by 
Analysis
Jade Biosciences (JBIO) Common Equity (2020 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Jade Biosciences came in at $332.52 million.
- In earlier years, Common Equity was -$46.8 million in FY2024, $109.46 million in FY2023 (-13.6%), $126.74 million in FY2022 (-26.5%) and $172.42 million in FY2021.
- The Q2 2026 figure marks the highest quarterly Common Equity in data going back to Q2 2020.
- The best year-over-year quarter for Common Equity over five years was Q2 2026 (growth of 118.3%); the worst was Q1 2023 (a decline of 30.2%).
- Per Business Quant data, JBIO's Common Equity in the three quarters before Q2 2026 was $296.46 million (Q1 2026), $332.52 million (Q4 2025) and $179.35 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Jade Biosciences | 912.03 Mn | 912.03 Mn | - | 439.92 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 439.92 Mn |
| Mar 31, 2026 | 296.46 Mn |
| Dec 31, 2025 | 332.52 Mn |
| Sep 30, 2025 | 179.35 Mn |
| Jun 30, 2025 | 201.56 Mn |
| Mar 31, 2025 | -83.51 Mn |
| Dec 31, 2024 | -46.80 Mn |
| Sep 30, 2024 | -16.86 Mn |
| Jun 30, 2024 | -589,000.00 |
| Mar 31, 2024 | 90.90 Mn |
| Dec 31, 2023 | 109.46 Mn |
| Sep 30, 2023 | 125.72 Mn |
| Jun 30, 2023 | 141.93 Mn |
| Mar 31, 2023 | 113.10 Mn |
| Dec 31, 2022 | 126.74 Mn |
| Sep 30, 2022 | 139.14 Mn |
| Jun 30, 2022 | 151.05 Mn |
| Mar 31, 2022 | 161.95 Mn |
| Dec 31, 2021 | 172.42 Mn |
| Sep 30, 2021 | 179.85 Mn |
API Access
Jade Biosciences Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=JBIO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "JBIO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=JBIO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();